查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930070

全球傷口閉合市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

Wound Closure Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 請詢問到貨日

價格

傷口閉合市場成長因子

2025年全球傷口閉合市場價值為151億美元。受外科手術數量增加和慢性病患病率上升的推動，預計該市場將在2026年達到160.9億美元，並在2034年達到283.4億美元。北美地區在傷口閉合市場中佔據領先地位，2025年市場佔有率為37.80%，這得益於其先進的醫院基礎設施、高額的醫療保健支出以及創新外科產品的快速普及。

傷口閉合利用縫線、縫合釘、止血劑和黏合劑等技術促進組織癒合和預防感染，在急救和外科手術中發揮著非常重要的作用。心血管、骨科、婦科和一般外科手術量的增加，顯著推動了醫療機構對高效傷口管理解決方案的需求。

市場驅動因素與成長因素

心血管疾病、骨科疾病、關節炎和糖尿病等慢性疾病的增加，導致全球住院率和手術干預率上升。老化人口尤其容易患上這些疾病，導致需要可靠傷口閉合產品的手術數量增加。

創傷病例和意外傷害的增加也促進了手術需求的成長。高效的傷口閉合系統對於骨折、內出血和組織損傷的緊急治療非常重要，這持續推動創傷中心和外科部門對這類產品的應用。

抗菌縫線、可吸收聚合物和生物活性止血劑等傷口閉合材料的創新，有助於改善癒合效果並減少手術部位感染。這些臨床優勢正促使醫院和門診手術中心以先進的傷口閉合解決方案取代傳統材料。

市場限制因素與成本障礙

儘管臨床需求強勁，但先進傷口閉合器械的高昂成本仍然是一個重要的限制因素，尤其是在新興經濟體。電動手術縫合器、專用止血鉗和塗層縫線的生產成本和監管合規成本都很高，導致最終用戶價格高昂。

此外，一些中低收入國家的保險覆蓋範圍限制進一步限制了手術的可及性，並限制了產品的供應。病患和醫院層面的經濟限制都會影響採購決策，尤其是對於價格較高的傷口閉合技術。

市場機會與監管支持

FDA 和 EMA 等監管機構的嚴格標準為成功獲得產品批准的製造商創造了機會。由於符合先進臨床要求的傷口閉合技術有限，因此投資於臨床試驗和安全性驗證的公司將獲得競爭優勢。

新型止血劑、縫線和手術吻合器的持續監管審批加速創新醫療器材的市場准入。人們對感染預防、手術安全和縮短恢復時間的日益關注，推動了多個外科專科對新一代傷口管理產品的需求。

市場挑戰

產品召回仍然是製造商面臨的一項重大營運挑戰。與器械故障、藥筒損壞、污染和標籤錯誤相關的召回會對醫院的信任度和監管監督產生負面影響。這些事件會擾亂供應鏈，增加合規成本，並給在該市場營運的公司帶來聲譽風險。

確保穩定的生產品質並進行上市後監測對於維持長期的市場信任和監管合規非常重要。

市場趨勢

傷口閉合市場的一個顯著趨勢是從傳統方法轉向先進的傷口閉合解決方案。外科醫師日益採用生物可吸收縫線、抗菌塗層和水膠體密封劑來促進組織癒合並降低感染風險。與傳統縫合技術相比，這些產品能夠提供更高的精確度和更穩定的臨床效果。

另一個主要趨勢是微創手術（MIS）的需求不斷成長。微創手術中產生的小切口需要使用專門的傷口閉合裝置，以促進快速癒合並最大程度地減少疤痕。在人們對更短恢復時間和更短住院時間的需求不斷成長的推動下，用於腹腔鏡和機器人手術的先進縫合系統正迅速普及。

市場區隔分析

依產品類型

依產品類型劃分，市場可分為縫合線、止血鉗、縫合器和其他。預計到2026年，縫線將以39.45%的市場佔有率引領市場，這主要得益於其在幾乎所有外科手術中的廣泛應用，以及可吸收和抗菌材料的持續創新。止血劑佔據第二大市場佔有率，這主要歸功於其在控制術中出血方面日益重要的作用。在手術量大的環境中，速度和一致性非常重要，因此縫合器的使用率持續成長。

依應用領域劃分

依應用領域劃分，市場佔有率涵蓋一般外科、心臟外科、骨科、婦產科、眼科及其他領域。到2026年，一般外科市場將佔據最大的市場佔有率，達到22.62%，這主要得益於闌尾切除術、疝氣修補術和膽囊手術數量的成長。心臟外科市場預計將因心臟手術的增加而快速成長。同時，骨科市場也受益於關節置換和創傷手術的增加。

依最終使用者劃分

依最終使用者劃分，市場可分為醫院/門診手術中心、專科診所及其他機構。醫院和門診手術中心預計將佔據市場主導地位，到2026年將佔據 69.90%的市場佔有率，這主要得益於較高的住院量、先進的手術基礎設施以及更完善的醫保覆蓋。專科診所，尤其是在城市地區，持續擴張，提供高強度的外科手術服務，並縮短患者等待時間。

區域展望

到2025年，北美市場規模達到 57.1億美元，這主要得益於較高的手術率、強大的保險覆蓋以及產品的快速普及。預計到2026年，美國市場規模將達到 55.9億美元，主要得益於慢性病盛行率的上升和持續的產品創新。

預計歐洲市場將因慢性病盛行率的上升以及政府為減少手術部位感染所採取的措施而成長。預計到2026年，英國市場規模將達到 9.7億美元，德國市場規模將達到 8.4億美元。

亞太地區正經歷顯著成長，這主要得益於龐大的患者群體和不斷成長的醫療保健投資。預計到2026年，中國市場規模將達到 9.8億美元，日本將達到 8.6億美元，印度將達到 6.8億美元，這得益於不斷擴大的外科手術能力和新醫療器材的監管審批。

拉丁美洲、中東和非洲預計將出現溫和成長，這主要得益於醫院基礎設施的改善以及公共醫療保健系統對外科手術認識的提高。

競爭格局與產業趨勢

傷口閉合市場的主要企業包括Johnson & Johnson Services, Inc.、Baxter、Medtronic、B. Braun SE、Stryker、Smith+Nephew、Boston Scientific Corporation、CooperSurgical、Genesis Medtech。這些公司正積極投資於產品發布、監管審批、全球擴張以及參與醫學會議，以增強品牌知名度和臨床應用。

近期行業趨勢包括機器人手術系統、先進的縫合釘平台、可吸收止血劑和創新縫合材料的獲批，所有這些都目的是提高手術精度和患者安全。持續的研發投入和監管審批增強其在已開發和新興醫療市場的競爭優勢。

分析範圍

全球傷口閉合市場報告全面分析了市場規模、產品細分、應用需求、終端用戶採納、區域表現、競爭策略和技術進步。本報告評估了將在2025年、2026年和2034年影響市場成長的醫療趨勢、手術量、監管框架和產品創新模式，為全球外科醫療器材行業的製造商、醫療服務提供者、分銷商和投資者提供策略見解。

縫合線、縫合器和止血鉗等技術的進步有助於提高手術精準度、降低感染風險並加快患者康復，推動了這些產品在醫院和門診手術中心（ASC）的應用。縫線市場佔有率預計在2026年將達到 39.45%，而醫院和門診手術中心（ASC）的市場佔有率高達 69.90%，這表明市場成長將繼續依賴手術量大的環境。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 各國及地區主要手術數（2025年）
  • 主要公司新產品發布
  • 傷口閉合市場的技術進步
  • 主要產業趨勢：併購、業務合作等

第5章 全球傷口閉合市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 縫合線
      • 可吸收縫合線
      • 不可吸收縫合線
    • 止血劑
      • 主動止血劑
      • 被動止血劑
      • 複方止血劑
      • 其他
    • 縫合器
      • 電動
      • 手動
    • 其他
  • 市場分析、洞察與預測：依用途與適應症劃分
    • 骨科
    • 婦產科
    • 其他外科手術
    • 眼科
    • 心臟科
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院及門診手術中心
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美傷口閉合市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲傷口閉合市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第8章 亞太地區傷口閉合市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 亞太其他地區

第9章 拉丁美洲傷口閉合市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第10章 中東與非洲傷口閉合市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • GCC國家
    • 南非
    • 中東其他地區非洲

第11章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
    • Johnson &Johnson Services, Inc.
    • Baxter
    • Medtronic
    • Artivion, Inc.
    • Stryker
    • 3M
    • CP Medical（Riverpoint Medical）
    • Boston Scientific Corporation
    • Smith+Nephew
    • B. Braun SE
    • MANI, INC.
    • CONMED Corporation
    • Genesis Medtech
    • CooperSurgical Inc.
    • Intuitive Surgical
    • Frankenman International Ltd.
Product Code: FBI102630

Growth Factors of wound closure Market

The global wound closure market size was valued at USD 15.10 billion in 2025. The market is projected to grow to USD 16.09 billion in 2026 and further reach USD 28.34 billion by 2034, reflecting strong expansion driven by rising surgical volumes and growing prevalence of chronic diseases. North America dominated the wound closure market with a 37.80% market share in 2025, supported by advanced hospital infrastructure, high healthcare spending, and rapid adoption of innovative surgical products.

Wound closure plays a critical role in emergency medicine and surgical procedures, involving techniques such as sutures, staplers, hemostatic agents, and adhesives used to promote tissue healing and prevent infections. Increasing numbers of cardiovascular, orthopedic, gynecological, and general surgeries are significantly increasing demand for effective wound management solutions across healthcare facilities.

Market Drivers and Growth Factors

The growing burden of chronic diseases such as cardiovascular disorders, orthopedic conditions, arthritis, and diabetes is increasing hospitalization rates and surgical interventions globally. A large portion of aging populations is particularly vulnerable to these conditions, leading to higher procedural volumes that require reliable wound closure products.

The rising number of trauma cases and accident-related injuries also contributes to increased surgical demand. Emergency procedures for fractures, internal bleeding, and tissue injuries rely heavily on efficient wound closure systems, which is driving consistent product utilization across trauma centers and surgical departments.

Technological innovation in wound closure materials, including antibacterial sutures, absorbable polymers, and bioactive hemostats, is improving healing outcomes and reducing surgical site infections. These clinical benefits are encouraging hospitals and ambulatory surgical centers to replace conventional materials with advanced wound closure solutions.

Market Restraints and Cost Barriers

Despite strong clinical demand, the high cost of advanced wound closure devices remains a major restraint, particularly in emerging economies. Powered surgical staplers, specialized hemostatic agents, and coated sutures involve high manufacturing and regulatory compliance costs, resulting in expensive end-user pricing.

Limited reimbursement coverage in several low- and middle-income countries further restricts access to surgical procedures, thereby limiting product utilization. Financial constraints at both patient and hospital levels affect procurement decisions, particularly for premium wound closure technologies.

Market Opportunities and Regulatory Support

Stringent regulatory standards imposed by agencies such as the FDA and EMA are creating opportunities for manufacturers that successfully achieve product approvals. As only a limited number of wound closure technologies meet advanced clinical requirements, companies investing in clinical trials and safety validation are gaining competitive advantages.

Ongoing regulatory approvals for new hemostats, sutures, and surgical staplers are accelerating market entry of innovative devices. Increased focus on infection prevention, surgical safety, and faster recovery outcomes is expanding demand for next-generation wound management products across multiple surgical specialties.

Market Challenges

Product recalls remain a critical operational challenge for manufacturers. Recalls related to device malfunctions, cartridge damage, contamination, and labeling errors negatively affect hospital trust and regulatory scrutiny. Such incidents disrupt supply chains, increase compliance costs, and create reputational risks for companies operating in this market.

Ensuring consistent manufacturing quality and post-market surveillance remains essential for sustaining long-term market confidence and regulatory compliance.

Market Trends

A significant trend in the wound closure market is the shift from traditional methods to advanced wound closure solutions. Surgeons are increasingly adopting bioresorbable sutures, antibacterial-coated materials, and hydrocolloid-based sealants that enhance tissue healing and reduce infection risks. These products offer better precision and consistent clinical outcomes compared to conventional closure techniques.

Another major trend is the rising preference for minimally invasive surgeries (MIS). Smaller incisions created during MIS procedures require specialized wound closure devices that promote rapid healing with minimal scarring. As demand for faster recovery and shorter hospital stays increases, advanced closure systems compatible with laparoscopic and robotic surgeries are witnessing strong adoption.

Segmentation Analysis

By Product Type

The market is segmented into sutures, hemostatic agents, staplers, and others. The sutures segment dominated the market with a 39.45% share in 2026, driven by widespread use across nearly all surgical procedures and continuous innovation in absorbable and antibacterial materials. Hemostatic agents hold the second-largest share due to their growing role in controlling intraoperative bleeding. Staplers continue to gain adoption in high-volume surgical environments where speed and consistency are critical.

By Application

Based on application, the market includes general surgery, cardiology, orthopedics, gynecology and obstetrics, ophthalmology, and others. The general surgery segment held the largest share at 22.62% in 2026, supported by high volumes of appendectomies, hernia repairs, and gallbladder surgeries. Cardiology is expected to grow rapidly due to increasing cardiac procedures, while orthopedics benefits from rising joint replacement and trauma surgeries.

By End User

The market is segmented into hospitals & ambulatory surgical centers, specialty clinics, and others. The hospitals & ASCs segment dominated with a 69.90% share in 2026, driven by high inpatient surgical volumes, access to advanced surgical infrastructure, and stronger reimbursement coverage. Specialty clinics continue to expand, particularly in urban regions, offering focused surgical services with shorter patient turnaround times.

Regional Outlook

North America recorded a market value of USD 5.71 billion in 2025, supported by high surgical rates, strong insurance coverage, and rapid product adoption. The U.S. market is projected to reach USD 5.59 billion by 2026 due to growing chronic disease prevalence and continuous product innovation.

Europe is experiencing growth driven by increasing chronic disease incidence and government initiatives to reduce surgical site infections. The UK market is projected to reach USD 0.97 billion by 2026, while Germany is projected to reach USD 0.84 billion by 2026.

Asia Pacific is witnessing strong expansion due to large patient populations and rising healthcare investments. By 2026, China is projected to reach USD 0.98 billion, Japan USD 0.86 billion, and India USD 0.68 billion, supported by expanding surgical capacity and regulatory approvals for new devices.

Latin America and the Middle East & Africa are experiencing gradual growth driven by improving hospital infrastructure and rising surgical awareness across public healthcare systems.

Competitive Landscape and Industry Developments

Key companies operating in the wound closure market include Johnson & Johnson Services, Inc., Baxter, Medtronic, B. Braun SE, Stryker, Smith+Nephew, Boston Scientific Corporation, CooperSurgical, and Genesis Medtech. These companies are actively investing in product launches, regulatory approvals, global expansion, and medical conference participation to strengthen brand visibility and clinical adoption.

Recent industry developments include approvals for robotic surgical systems, advanced stapling platforms, absorbable hemostatic agents, and innovative suture materials aimed at improving surgical precision and patient safety. Continuous R&D investments and regulatory clearances are strengthening competitive positioning across both developed and emerging healthcare markets.

Report Coverage

The wound closure market report provides comprehensive analysis of market size, product segmentation, application-based demand, end-user adoption, regional performance, competitive strategies, and technological advancements. The report evaluates healthcare trends, surgical procedure volumes, regulatory frameworks, and product innovation patterns shaping market growth between 2025, 2026, and 2034, offering strategic insights for manufacturers, healthcare providers, distributors, and investors operating within the global surgical device industry.

Conclusion

The wound closure market is showing strong and consistent expansion, with the global market valued at USD 15.10 billion in 2025, projected to reach USD 16.09 billion in 2026, and expected to grow further to USD 28.34 billion by 2034. This growth is primarily driven by the rising number of surgical procedures associated with chronic diseases, trauma cases, and age-related medical conditions, which are increasing the demand for reliable and efficient wound management solutions across healthcare systems.

Technological advancements in sutures, staplers, and hemostatic agents are improving surgical precision, reducing infection risks, and supporting faster patient recovery, which is strengthening adoption across hospitals and ambulatory surgical centers. The dominance of the sutures segment with a 39.45% share in 2026 and the strong presence of hospitals & ASCs with a 69.90% share in 2026 highlight the continued reliance on high-volume surgical environments for market growth.

Segmentation By Product Type

  • Sutures
    • Absorbable
    • Non-Absorbable
  • Hemostatic Agents
    • Active Hemostats
    • Passive Hemostats
    • Combination Hemostats
    • Others
  • Staplers
    • Powered
    • Manual
  • Others

By Application

  • Orthopedics
  • Gynecology and Obstetrics
  • General Surgery
  • Ophthalmology
  • Cardiology
  • Others

By End-user

  • Hospitals & ASCs
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Application, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Key Procedures, by Key Countries/Region, 2025
  • 4.2. New Product Launches - by Key Players
  • 4.3. Technological Advancements in Wound Closure Market
  • 4.4. Key Industry Developments - (Mergers, Acquisitions, Partnerships, etc.)

5. Global Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Sutures
      • 5.1.1.1. Absorbable
      • 5.1.1.2. Non-absorbable
    • 5.1.2. Hemostatic Agents
      • 5.1.2.1. Active Hemostats
      • 5.1.2.2. Passive Hemostats
      • 5.1.2.3. Combination Hemostats
      • 5.1.2.4. Others
    • 5.1.3. Staplers
      • 5.1.3.1. Powered
      • 5.1.3.2. Manual
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Orthopedics
    • 5.2.2. Gynecology and Obstetrics
    • 5.2.3. General Surgery
    • 5.2.4. Ophthalmology
    • 5.2.5. Cardiology
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Sutures
      • 6.1.1.1. Absorbable
      • 6.1.1.2. Non-absorbable
    • 6.1.2. Hemostatic Agents
      • 6.1.2.1. Active Hemostats
      • 6.1.2.2. Passive Hemostats
      • 6.1.2.3. Combination Hemostats
      • 6.1.2.4. Others
    • 6.1.3. Staplers
      • 6.1.3.1. Powered
      • 6.1.3.2. Manual
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Orthopedics
    • 6.2.2. Gynecology and Obstetrics
    • 6.2.3. General Surgery
    • 6.2.4. Ophthalmology
    • 6.2.5. Cardiology
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Sutures
      • 7.1.1.1. Absorbable
      • 7.1.1.2. Non-absorbable
    • 7.1.2. Hemostatic Agents
      • 7.1.2.1. Active Hemostats
      • 7.1.2.2. Passive Hemostats
      • 7.1.2.3. Combination Hemostats
      • 7.1.2.4. Others
    • 7.1.3. Staplers
      • 7.1.3.1. Powered
      • 7.1.3.2. Manual
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Orthopedics
    • 7.2.2. Gynecology and Obstetrics
    • 7.2.3. General Surgery
    • 7.2.4. Ophthalmology
    • 7.2.5. Cardiology
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Sutures
      • 8.1.1.1. Absorbable
      • 8.1.1.2. Non-absorbable
    • 8.1.2. Hemostatic Agents
      • 8.1.2.1. Active Hemostats
      • 8.1.2.2. Passive Hemostats
      • 8.1.2.3. Combination Hemostats
      • 8.1.2.4. Others
    • 8.1.3. Staplers
      • 8.1.3.1. Powered
      • 8.1.3.2. Manual
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Orthopedics
    • 8.2.2. Gynecology and Obstetrics
    • 8.2.3. General Surgery
    • 8.2.4. Ophthalmology
    • 8.2.5. Cardiology
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Sutures
      • 9.1.1.1. Absorbable
      • 9.1.1.2. Non-absorbable
    • 9.1.2. Hemostatic Agents
      • 9.1.2.1. Active Hemostats
      • 9.1.2.2. Passive Hemostats
      • 9.1.2.3. Combination Hemostats
      • 9.1.2.4. Others
    • 9.1.3. Staplers
      • 9.1.3.1. Powered
      • 9.1.3.2. Manual
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Orthopedics
    • 9.2.2. Gynecology and Obstetrics
    • 9.2.3. General Surgery
    • 9.2.4. Ophthalmology
    • 9.2.5. Cardiology
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Wound Closure Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Sutures
      • 10.1.1.1. Absorbable
      • 10.1.1.2. Non-absorbable
    • 10.1.2. Hemostatic Agents
      • 10.1.2.1. Active Hemostats
      • 10.1.2.2. Passive Hemostats
      • 10.1.2.3. Combination Hemostats
      • 10.1.2.4. Others
    • 10.1.3. Staplers
      • 10.1.3.1. Powered
      • 10.1.3.2. Manual
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Orthopedics
    • 10.2.2. Gynecology and Obstetrics
    • 10.2.3. General Surgery
    • 10.2.4. Ophthalmology
    • 10.2.5. Cardiology
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Baxter
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Medtronic
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Artivion, Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Stryker
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. 3M
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. CP Medical (Riverpoint Medical)
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Boston Scientific Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Smith+Nephew
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. B. Braun SE
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. MANI, INC.
      • 11.2.11.1. Overview
      • 11.2.11.2. Products
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. CONMED Corporation
      • 11.2.12.1. Overview
      • 11.2.12.2. Products
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)
    • 11.2.13. Genesis Medtech
      • 11.2.13.1. Overview
      • 11.2.13.2. Products
      • 11.2.13.3. SWOT Analysis
      • 11.2.13.4. Recent Developments
      • 11.2.13.5. Strategies
      • 11.2.13.6. Financials (Based on Availability)
    • 11.2.14. CooperSurgical Inc.
      • 11.2.14.1. Overview
      • 11.2.14.2. Products
      • 11.2.14.3. SWOT Analysis
      • 11.2.14.4. Recent Developments
      • 11.2.14.5. Strategies
      • 11.2.14.6. Financials (Based on Availability)
    • 11.2.15. Intuitive Surgical
      • 11.2.15.1. Overview
      • 11.2.15.2. Products
      • 11.2.15.3. SWOT Analysis
      • 11.2.15.4. Recent Developments
      • 11.2.15.5. Strategies
      • 11.2.15.6. Financials (Based on Availability)
    • 11.2.16. Frankenman International Ltd.
      • 11.2.16.1. Overview
      • 11.2.16.2. Products
      • 11.2.16.3. SWOT Analysis
      • 11.2.16.4. Recent Developments
      • 11.2.16.5. Strategies
      • 11.2.16.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 3: Global Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 4: Global Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 5: Global Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 6: Global Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Wound Closure Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 9: North America Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 10: North America Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 11: North America Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 12: North America Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: North America Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Wound Closure Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 16: Europe Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 17: Europe Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 18: Europe Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 19: Europe Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 20: Europe Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 21: Europe Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 23: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 24: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 25: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 26: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 28: Asia Pacific Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 30: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 31: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 32: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 33: Latin America Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Latin America Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 35: Latin America Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 37: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Sutures, 2021-2034
  • Table 38: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Hemostatic Agents, 2021-2034
  • Table 39: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Staplers, 2021-2034
  • Table 40: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 42: Middle East & Africa Wound Closure Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Wound Closure Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Wound Closure Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Wound Closure Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Wound Closure Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Wound Closure Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 7: North America Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Wound Closure Market Value Share (%), by Application, 2025
  • Figure 10: North America Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Wound Closure Market Value Share (%), by End User, 2025
  • Figure 12: North America Wound Closure Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Wound Closure Market Value Share (%), By Country, 2025
  • Figure 14: Europe Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 15: Europe Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Wound Closure Market Value Share (%), by Application, 2025
  • Figure 18: Europe Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Wound Closure Market Value Share (%), by End User, 2025
  • Figure 20: Europe Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Wound Closure Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Wound Closure Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 31: Latin America Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Wound Closure Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Wound Closure Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Wound Closure Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Wound Closure Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Wound Closure Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Wound Closure Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Wound Closure Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Wound Closure Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Wound Closure Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Wound Closure Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Wound Closure Market Share (%), By Company, 2025
  • Figure 47: Global Staplers Market Share (%), By Company, 2025